Suppr超能文献

经髂外静脉经皮插入长期静脉通路导管。

Percutaneous insertion of long-term venous access catheters via the external iliac vein.

作者信息

Mathur M N, Storey D W, White G H, Ramsey-Stewart G

机构信息

Department of Upper Gastrointestinal Surgery and Parenteral Nutrition, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

出版信息

Aust N Z J Surg. 1993 Nov;63(11):858-63. doi: 10.1111/j.1445-2197.1993.tb00360.x.

Abstract

Long-term venous access using Hickman catheters and implantable subcutaneous ports is a well established technique. These devices have customarily been inserted via the internal jugular, subclavian or cephalic veins. On occasions, these routes may be unavailable. This article reviews the outcome of 53 prolonged venous access catheters (39 Hickmans and 14 catheters attached to implantable ports) inserted percutaneously via the external iliac vein into 37 patients over a period of 5.7 years. The indications for insertion were chemotherapy (40%), total parenteral nutrition (36%), intravenous antibiotics (13%), poor venous access (7%) and bone marrow transplantation (4%). The main reasons for use of the external iliac vein were thrombosis of the subclavian veins or superior vena cava and subclavian central line sepsis. The only complication of insertion was one inadvertent puncture of the external iliac artery. Twenty-seven catheters (51%) remained complication free and functioning for the time for which they were required. Four catheters (7%) are still functioning in situ having been present for 1-5 years. Sixteen catheters (30%) became infected, with a 17% incidence of septicaemia. Venous thrombosis was associated with three catheters (6%). Catheters remained in situ for a median period of 30 days (range 5-569 days). The authors conclude that long-term venous access using percutaneous external iliac vein insertion is a useful technique when other routes are unavailable, but there is a relatively high incidence of catheter-related sepsis.

摘要

使用希克曼导管和植入式皮下端口进行长期静脉通路建立是一项成熟的技术。这些装置通常通过颈内静脉、锁骨下静脉或头静脉插入。有时,这些途径可能不可用。本文回顾了在5.7年的时间里,经皮通过髂外静脉为37例患者插入53根长期静脉通路导管(39根希克曼导管和14根连接植入式端口的导管)的结果。插入的适应证为化疗(40%)、全胃肠外营养(36%)、静脉用抗生素(13%)、静脉通路差(7%)和骨髓移植(4%)。使用髂外静脉的主要原因是锁骨下静脉或上腔静脉血栓形成以及锁骨下中心静脉导管败血症。插入的唯一并发症是1例意外穿刺髂外动脉。27根导管(51%)在所需时间内无并发症且功能良好。4根导管(7%)已在位1至5年,仍在原位发挥作用。16根导管(30%)发生感染,败血症发生率为17%。3根导管(6%)出现静脉血栓形成。导管在位的中位时间为30天(范围5至569天)。作者得出结论,当其他途径不可用时,经皮髂外静脉插入进行长期静脉通路建立是一项有用的技术,但导管相关败血症的发生率相对较高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验